Hirotake Tokuyama
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME-V study).
Journal: Journal of diabetes investigation
Published: February 18, 2020
Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study).
Journal: Diabetes, obesity & metabolism
Published: January 11, 2019
N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.
Journal: Lipids in health and disease
Published: December 11, 2017
Outcomes of laparoscopic sleeve gastrectomy in elderly obese Japanese patients.
Journal: Geriatrics & gerontology international
Published: October 18, 2016
Sitagliptin but not alpha glucosidase inhibitor reduced the serum soluble CD163, a marker for activated macrophage, in individuals with type 2 diabetes mellitus.
Journal: Diabetes research and clinical practice
Published: August 23, 2016
Combination of cilostazol and probucol protected podocytes from lipopolysaccharide-induced injury by both anti-inflammatory and anti-oxidative mechanisms.
Journal: Journal of nephrology
Published: March 16, 2016
Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARγ directs early activation of T cells.
Journal: Nature communications
Published: March 02, 2016
Obesity Drives Th17 Cell Differentiation by Inducing the Lipid Metabolic Kinase, ACC1.
Journal: Cell reports
Published: November 17, 2014
Pituitary adenylate cyclase-activating polypeptide protects glomerular podocytes from inflammatory injuries.
Journal: Journal of diabetes research
Published: November 14, 2014
A low-grade increase of serum pancreatic exocrine enzyme levels by dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes.
Journal: Diabetes research and clinical practice
Published: July 10, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026